StemEdit iMSC B2M/CIITA DKO hTERT SV40 ReproMSC18
Reprocell

StemEdit iMSC B2M/CIITA DKO hTERT SV40 ReproMSC18

QTYCat # SizeUnit Price
RCRP058 1 vial (1 million cells) $4,900.00

* Prices listed are in USD. Taxes, shipping & handling not included. Contact us for bulk pricing.

Add to My Quote
Have questions? Message Us

Overview

Ready-to-use, Research-grade Human iMSCs with B2M and CIITA Double Knockout, immortalized with hTERT and SV40

Repro MSC18 are ready-to-use iPSC-derived mesenchymal stem cells (iMSCs) generated from StemEdit iMSC B2M/CIITA DKO ReproMSC14 (Cat. No. RCRP057) by constitutive immortalization with hTERT and SV40. The original parent of ReproMSC18 is a gene-edited version of one of our StemRNA™ Clinical Lines, RPC-LLF-34-F3.  

Advantages of ReproMSC18

  • Combines hypoimmune engineering and immortalization in a single iMSC platform
  • Reduces immune recognition while sustaining proliferative capacity
  • Provides enhanced scalability, reproducibility, and manufacturing consistency

ReproMSC18 cells do not contain Phenol Red, making them ideal for exosome research.

iMSCs offer several advantages over primary MSCs, including a renewable cell source, enhanced scalability, greater batch-to-batch consistency, high proliferative capacity, and suitability for genetic engineering. Find out more about their potential therapeutic advantages in our recent blog post "The Therapeutic Advantage of Induced Pluripotent Stem Cells-Derived Mesenchymal Stem Cells (iMSCs)".

ReproMSC18 cells feature:

  • Easy access to hypoimmune MSCs from a reproducible source.
  • Immediate thawing into Phenol Red-free MSC NutriStem XF Culture medium (Cat. No. 01-0007) on vitronectin or NutriCoat™ Attachment Solution (Cat. No. 05-0063) with easy conversion to other standard MSC Media.

NOTE:  

These iMSC cell lines are developed and supplied for Research Use Only (RUO). They are not intended for clinical or therapeutic applications. However, the iPSC clone from which these iMSCs were derived has a clinical-grade iPSC counterpart that is suitable for clinical gene editing and downstream clinical development. If you require material for translational or clinical programs, please see Clinical Stem Cell Services or Contact Us for more information.

See also:


Table: Characteristics of StemEdit iMSC B2M/CIITA DKO hTERT SV40 ReproMSC18 Cells
Cat. No.:  RCRP058
Mutation: B2M/CIITA double knockout
Mutation validation:

DNA Sequencing, B2M expression (flow)

Parent Clone ID:

StemEdit hiPSC B2M/CIITA DKO (Cat. No. RCRP052), which were derived from StemRNA Clinical iPSC Clone LLF-34-F3

Donor Blood Type:

O positive

Donor Race: Caucasian
Donor Sex: Female
Donor Age: 22
Reprogramming Technology: StemRNA Clinical Reprogramming Technology
Tissue Source: Skin (Fibroblasts)
Microbiology: Negative for bacteria, viruses, and mycoplasma

Specifications

Product Name: StemEdit iMSC B2M/CIITA DKO hTERT SV40 ReproMSC18

Catalog Number: RCRP058

Product Description: ReproMSC18 are ready-to-use, research-grade Human iMSCs generated from one of our StemRNA™ Clinical Lines, RPC-LLF-34-F3, that were immortalized with hTERT and SV40. The parental iPSC line was established from fibroblasts using the StemRNA Reprogramming Technology that was subsequently engineered with biallelic knockouts of B2M and CIITA, key regulators of HLA Class I and Class II antigen presentation.

Clone: ReproMSC18

Passage Number: See lot-specific datasheet

Donor Information

  • Race: Caucasian
  • Sex: Female
  • Age: 22 years old

Precryopreservation Culture Conditions

  • Culture Medium: MSC NutriStem® XF Culture Medium, Phenol Red Free (Cat. No. 01-0007)
  • Culture Matrix: Vitronectin
  • Cryopreservation Medium: NutriFreezTM D10 Cryopreservation Medium, Phenol Red-free (Cat. No. 01-0031-50)

Size: 1 vial, 1 million cells per vial

Storage: Store in liquid nitrogen vapor phase.

Quality Control

  • MSC markers by FCS: Pass
  • Bacteria: Negative
  • Mycoplasma: Negative
  • Virus (HIV1&2, HBV, HCV): Negative
  • Viability after thaw: >70%

Sterility: Sterile

Notice To Purchaser: This product is intended for Research Use Only.  Commercial Use may require additional agreements. Please contact info-us@reprocell.com for more information.  Not intended for Therapeutic or Diagnostic uses.